Crystal Clear opens the episode by contributing a brand-new condition to the diagnostic literature: Delusional Debunking Disorder, or DDD. The case study is Mick West, who has spent twenty years insisting Morgellons fibers are lint and Havana Syndrome is crickets.
Crystal pivots to chat about Chen Tianqiao, Shanda Group founder and CCP member, who quietly bought roughly 200,000 acres in Klamath and Deschutes counties through a shell company called Whitefish Forest Resources in February 2015h. Second-largest foreign land purchase in American history.
The data point that refuses to sit down: Google Trends shows Oregon Morgellons searches at zero the week of the transaction. Five weeks later, March 29, 2015, the spike hits one hundred. Lagged correlation coefficient 0.92. Top two Oregon metros for Morgellons search interest that year: Bend in Deschutes County, and Medford-Klamath Falls. Whatever drove the search spike was not news. It was something people were feeling in their bodies.
Crystal traces what Chen did next. One billion dollars committed to neuroscience. The Tianqiao Chen Institute for Neuroscience at Caltech, $115 million. A Fudan University partnership in Shanghai. And NeuroXess, his implantable BCI company, whose chief scientist Tiger Tao specializes in silktrodes. January 2026: NeuroXess breaks ground on a super factory in Nanshang. March 2026: China issues the world’s first commercial approval for an invasive BCI device.
Enter billionaire number two. Joe Tsai, Alibaba co-founder, funder of the Wu Tsai Neurosciences Institute at Stanford, the Wu Tsai Institute at Yale, and a $220 million Human Performance Alliance that includes the University of Oregon.
Then the digital twin layer. Jensen Huang, NVIDIA CEO and Oregon State alum, donated fifty million dollars for an NVIDIA supercomputer at OSU Corvallis built for “complex twin simulations.” Ninety minutes from Eugene, the number five Morgellons search metro in America. Oklahoma State launched its Digital Human Twin Consortium in January 2025, also NVIDIA-powered, and happens to sit on Dr. Randy Wymore’s twenty-year Morgellons patient registry, possibly twelve thousand families, the largest biological data repository on the condition anywhere. They still ignore Crystal’s open records requests.
The sensor layer is Profusa, DARPA and Shanghai-funded, CEO Ben Hwang, manufacturer of injectable hydrogel biosensors. They just partnered with NVIDIA to build the AI portal reading the data. Sensors in, data out, twin built.
The deepest cut is the 2001 material. Weinong Fu, computational electromagnetics specialist at Ansoft in Pittsburgh, the company whose software gets implantable devices through FDA approval, posted a web page from his corporate email in May 2001 collecting Morgellons symptom reports from Americans. His wife Li Honglui was simultaneously co-funding a Fudan University paper documenting an unidentified organism producing “creeping eruptions, migratory pain, and neurofilament damage.” American arm, Chinese arm, Pittsburgh modeling layer.
The episode closes on the new Morgellons metagenomics preprint that landed on bioRxiv in April 2026, the first substantial research since Middelveen 2018. Crystal notes the venue: bioRxiv runs on Cold Spring Harbor Laboratory, home of the Eugenics Record Office until Carnegie pulled funding, and has been bankrolled since 2017 by the Chan Zuckerberg Initiative. The paper itself gets its full deep-dive on Jeremy Murphree’s Morgellons Discussion podcast. Check it out!
A 0.92 correlation does not care about anyone’s opinion. A 2001 paper does not retroactively become a coincidence because it is inconvenient. And nobody buys 200,000 acres in the highest-Morgellons-search state while building a silk fiber brain implant factory unless those two investments are chapters in the same business plan.